[1]谢 华,周毅峰,甘晓庆,等.血液透析专用中心静脉导管封管液的研究[J].医学信息,2019,32(18):48-50.[doi:10.3969/j.issn.1006-1959.2019.18.016]
　XIE Hua,ZHOU Yi-feng,GAN Xiao-qing,et al.Research on Central Venous Catheter Sealing Fluid for Hemodialysis[J].Journal of Medical Information,2019,32(18):48-50.[doi:10.3969/j.issn.1006-1959.2019.18.016]
点击复制

血液透析专用中心静脉导管封管液的研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年18期
页码:
48-50
栏目:
综述
出版日期:
2019-09-15

文章信息/Info

Title:
Research on Central Venous Catheter Sealing Fluid for Hemodialysis
文章编号:
1006-1959（2019）18-0048-03
作者:
谢 华; 周毅峰; 甘晓庆; 蔡益民
湖南省人民医院手术一部，湖南 长沙 410000
Author(s):
XIE Hua; ZHOU Yi-feng; GAN Xiao-qing; CAI Yi-min
Department of Surgery,Division One,Hunan Provincial People's Hospital,Changsha 410000,Hunan,China
关键词:
血液透析; 中心静脉导管; 封管液; 枸橼酸钠; 肝素
Keywords:
Key words：Hemodialysis; Central venous catheter; Sealing solution; Sodium citrate; Heparin
分类号:
R459.5
DOI:
10.3969/j.issn.1006-1959.2019.18.016
文献标志码:
A
摘要:
在为血液透析专用中心静脉导管患者进行封管时，封管液的选择会影响封管的效果。目前对于何种封管液有最佳的抗栓效果及较好的安全性，国内外对枸橼酸钠与肝素封管液的效果存在一些争议。如何延长中心静脉导管留置的时间，以及减少导管并发症的发生是临床急需解决的问题。本文就血液透析专用中心静脉导管封管液枸橼酸钠和肝素对凝血功能、导管堵管率以及导管功能相关血流感染的影响等方面展开综述，为临床护理工作提供相关证据。
Abstract:
Abstract：When sealing a patient with a central venous catheter for hemodialysis, the choice of the sealing fluid affects the effectiveness of the sealing tube. At present, there is some controversy about the effect of sodium citrate and heparin sealing solution on the optimal antithrombotic effect and better safety of the sealing liquid. How to prolong the time of central venous catheter indwelling and reduce the occurrence of catheter complications is an urgent problem to be solved. This article summarizes the effects of sodium citrate and heparin on hemodialysis-specific central venous catheter sealing solution on coagulation function, catheter catheterization rate and catheter function-related bloodstream infection, and provides relevant evidence for clinical nursing work.

参考文献/References:

[1]陈新,姚利群.枸橼酸钠和肝素钠用于血液透析导管封管有效性的对比[J].基因组学与应用生物学,2018,37(7):3080-3084. [2]Correa Barcellos F,Pereira Nunes B,Jorge Valle L,et al.Comparative effectiveness of 30% trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters:a randomized controlled trial(CITRIM trial)[J].Infection,2017,45(2):139-145. [3]王玉柱,叶朝阳,金其庄.中国血液透析用血管通路专家共识(第1版)[J].中国血液净化,2014,13(8):549-558. [4]杨松涛,刘占肖,张庆娴,等.不同浓度肝素封管液对常规凝血功能和血栓弹力图的影响[J].中国血液净化,2015,14(6):371-374. [5]汪晶,何燕.枸橼酸钠用于血液透析导管封管的效果观察[J].基因组学与应用生物学,2018,37(12):5609-5615. [6]王明波,王自良,谭永顺.枸橼酸钠与肝素钠应用于血液透析患者封存Cuff导管的安全性和有效性对照研究[J].实用药物与临床,2016,19(7):869-872. [7]马驰骋.在肝素抗凝的连续肾脏替代治疗中活化部分凝血活酶时间适宜时间的研究[J].中国全科医学,2010,13(18):1992-1993. [8]邹懿.枸橼酸和不同浓度肝素用于中心静脉导管封管对凝血时间的效果分析[J].当代医学,2011,17(33):100-101. [9]张凌.枸橼酸抗凝在持续缓慢低效血液透析中的疗效和安全性[J].中华内科杂志,2013,52(6):459-463. [10]Boersma RS,Jie KS,Voogd AC,et al.Concentrated citrate locking in order to reduce the long-term complications of central venous catheters:a randomized controlled trial in patients with hematological malignancies[J].Supportive Care in cancer,2015,23(1):37-45. [11]焦梅,李艳慧,李康峰,等.不同比例的硫酸鱼精蛋白与肝素钠在高危出血倾向患者血液净化中的应用效果[J].解放军护理杂志,2014,31(13):11-13. [12]崔琳琳,叶朝阳.中心静脉长期留置导管常用封管液及封管方法[J].中国血液净化,2015,14(1):5-9. [13]陈爱武.两种不同封管方法在血液透析中的应用效果比较[J].中国医药导报,2010,7(16):33-34. [14]杨松涛,刘占肖.不同浓度肝素封管液对常规凝血功能和血栓弹力图的影响[J].中国血液净化,2015,14(6):371-374. [15]黎磊石,季大玺.连续性血液净化[M].南京:东南大学出版社,2010:20-50. [16]李春燕.美国INS2016版《输液治疗实践标准》要点解读[J].中国护理管理,2017,17(2):150-153. [17]Moran JE,Ash SR,ASDIN Clinical Practice Committee.Locking solutions for hemodialysis catheters:heparin and citrate——a position paper by ASDIN[J].Semin Dial,2008,21(5):490-492. [18]Lok CE,Appleton D,Bhola C,et al.Trisodium citrate 4%——an alternative to heparin capping of hemodialysis catheters[J].Nephrol Dial Transplant,2007,22(2):477-483. [19]张珂,孔凌,龚德华,等.改良枸橼酸输注法对连续性血液净化患者体外循环凝血的影响[J].解放军护理杂志,2018,35(10):25-28. [20]洪冬梅,周玉坤,李康峰,等.高浓度枸橼酸钠与局部肝素体外抗凝在血液净化伴出血倾向患者中运用的效果[J].解放军护理杂志,2016,33(12):71-73. [21]Bruyère R,Soudry-Faure A,Capellier G,et al.Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure(VERROU-REA study):study protocol for a randomized controlled trial[J].BioMed Central,2014(15):449. [22]樊蓉,孔凌,邹华,等.降低连续性血液净化体外循环凝血导致非计划性下机发生率的实践[J].中国护理管理,2015,15(4):475-477. [23]马逊,朱亚梅,吕小林,等.不同血液透析预冲方法对透析器凝血的影响[J].护理学报,2012,19(1):42-44. [24]Luiz MV,Scavone C,Tzanno C.The CLOCK trial,a double-blinded randomized controlled trial:Trisodium citrate 30% and minocycline 3 mg/mL plus EDTA 30 mg/mL are effective and safe for catheter patency maintenance among CKD 5D patients on hemodialysis[J].Hemodialysis International,2017,21(2):294-304. [25]金艳鸿,尹璐.三种封管液对血滤患者中心静脉导管封管效果的比较研究[J].中国医药导报,2017,14(28):178-180. [26]Moore CL,Besarab A,Ajluni M,et al.Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients[J].Clin J Am Soc Nephrol,2014,9(7):1232-1239. [27]檀敏,翟薇.加强透析室感染控制提高患者生存质量[J].中国护理管理,2010,10(7):68-70. [28]Nguyen DB,Shugart A,Lines C,et al.National Healthcare Safety Network(NHSN)Dialysis Event Surveillance Report for 2014[J].Clin J Am Soc Nephrol,2017,12(7):1139-1146. [29]Pittiruti M,Bertoglio S,Scoppettuolo G,et al.Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters(excluding dialysis catheters):a GAVeCeLT consensus[J].J Vasc Access,2016,17(6):453-464. [30]Vercaigne LM,Allan DR,Armstrong SW,et al.An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections:a randomized pilot study[J].J Vasc Access,2016,17(1):55-62.

相似文献/References:

[1]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
　XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Journal of Medical Information,2018,31(18):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
[2]邹 鑫,刘秀娟,余燕燕.血液透析对MHD患者血清FGF-23水平与 钙磷代谢的影响[J].医学信息,2018,31(09):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
　ZOU Xin,LIU Xiu-juan,YU Yan-yan.Effect of Hemodialysis on Serum FGF-23 Level and Calcium and Phosphorus Metabolism in MHD Patients[J].Journal of Medical Information,2018,31(18):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
[3]王允彦.西那卡塞对维持性血液透析继发性甲状旁腺功能亢进患者FGF-23的影响[J].医学信息,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
　WANG Yun-yan.Effect of Cinacalcet on FGF-23 in Patients with Secondary Hyperparathyroidism during Maintenance Hemodialysis[J].Journal of Medical Information,2018,31(18):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
[4]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
　FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Journal of Medical Information,2019,32(18):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[5]蒋红利,刘 华,史珂慧,等.陕西省县级医院透析室建设项目培训效果评价[J].医学信息,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
　JIANG Hong-li,LIU Hua,SHI Ke-hui,et al.Evaluation on Training Effect of Dialysis Room Construction Project in County Hospitals in Shaanxi Province[J].Journal of Medical Information,2018,31(18):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
[6]张民霞.血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果[J].医学信息,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
　ZHANG Min-xia.Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure[J].Journal of Medical Information,2019,32(18):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
[7]喻学娜.协同护理对终末期肾脏病血液透析患者自我护理能力及治疗依从性的影响[J].医学信息,2019,32(20):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
　YU Xue-na.Effect of Collaborative Nursing on Self-care Ability and Treatment Compliance of Hemodialysis Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(18):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
[8]魏昌林.血液透析联合血液灌流在终末期肾病患者治疗中的应用[J].医学信息,2019,32(13):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
　WEI Chang-lin.Application of Hemodialysis Combined with Blood Perfusion in the Treatment of Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(18):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
[9]王艳霞.中药灌肠对尿毒症血液透析患者便秘、食欲减退及呕吐等不良反应的影响[J].医学信息,2022,35(17):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
　WANG Yan-xia.Effect of Traditional Chinese Herb Enema on Adverse Reactions of Constipation,Loss of Appetite and Vomiting in Uremic Hemodialysis Patients[J].Journal of Medical Information,2022,35(18):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
[10]钟瑜辉.血液透析联合血液灌流治疗尿毒症的效果[J].医学信息,2019,32(21):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]
　ZHONG Yu-hui.Effect of Hemodialysis Combined with Blood Perfusion on Uremia[J].Journal of Medical Information,2019,32(18):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]

更新日期/Last Update: 2019-09-15